Novel Oliveros-like Clade C Mammarenaviruses from Rodents in Argentina, 1990-2020

Viruses. 2024 Feb 22;16(3):340. doi: 10.3390/v16030340.

Abstract

Following an Argentine Hemorrhagic Fever (AHF) outbreak in the early 1990s, a rodent survey for Junín virus, a New World Clade B arenavirus, in endemic areas of Argentina was conducted. Since 1990, INEVH has been developing eco-epidemiological surveillance of rodents, inside and outside the Argentine Hemorrhagic Fever endemic area. Samples from rodents captured between 1993 and 2019 that were positive for Arenavirus infection underwent Sanger and unbiased, Illumina-based high-throughput sequencing, which yielded 5 complete and 88 partial Mammarenaviruses genomes. Previously, 11 genomes representing four species of New World arenavirus Clade C existed in public records. This work has generated 13 novel genomes, expanding the New World arenavirus Clade C to 24 total genomes. Additionally, two genomes exhibit sufficient genetic diversity to be considered a new species, as per ICTV guidelines (proposed name Mammarenavirus vellosense). The 13 novel genomes exhibited reassortment between the small and large segments in New World Mammarenaviruses. This work demonstrates that Clade C Mammarenavirus infections circulate broadly among Necromys species in the Argentine Hemorrhagic Fever endemic area; however, the risk for Clade C Mammarenavirus human infection is currently unknown.

Keywords: Argentina; Mammarenaviruses; Necromys; phylogenetics; sequencing.

MeSH terms

  • Animals
  • Arenaviridae* / genetics
  • Arenavirus* / genetics
  • Arenaviruses, New World* / genetics
  • Argentina / epidemiology
  • Hemorrhagic Fever, American* / epidemiology
  • Humans
  • Junin virus* / genetics
  • Rodentia

Grants and funding

This research was supported by Cooperative Agreement Number NU60OE000104 (CFDA #93.322) and funded by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) (Viral Special Pathogen’s Branch Core funds), Pan American Health Organization, and Instituto Nacional de Enfermedades Virales Humanas. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of PAHO, INEVH, CNIN-ANLIS, Government of Argentina, APHL, CDC, HHS or the US Government.